ACTG 333: Antiviral effects of switching from saquinavir hard capsule (SQVhc) to saquinavir soft gelatin capsule (SQVsgc) vs. switching to indinavir (IDV) after prior saquinavir

Clinical Infectious Diseases

Volumn 25, Issue 2, 1997, Pages 359-

  Para, M F ^a   Collier, A ^b   Coombs, R ^b   Glidden, D ^e   Bassett, R ^e   Duff, F ^c   Leavitt, R Y ^d   Petttnelli, C ^e  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 20644433904     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)